Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer
Status:
Completed
Trial end date:
2016-09-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether or not the combination of cisplatin, irinotecan
and radiation, followed by surgery, followed by oral Sutent, is effective and safe for
patients with resectable esophageal cancer.